Anti-Cancer Drugs Publishes Preclinical Data Demonstrating
Misetionamide showed broad antineoplastic activity in 15 different cancer types including multiple human cancer cell lines with no detrimental effect on...
Greg Bosch Sara Krane Lisa Descenza Panavance Therapeutics Inc Head Nonclinical Research Anti Cancer Drugs
Source: globenewswire.com